The O-specific polysaccharide of Klebsiella pneumoniae in patients with bloodstream infections is immunogenic, and its closely related subtypes are cross-reactive.

A study has established the importance of immunoglobulin A, an antibody that is part of the immune system, in generating a response to pneumonia vaccines. Researchers have found that the absence of ...

ORLANDO -- More than 80% of patients with moderate or severe atopic dermatitis (AD) had at least 75% improvement after 12 ...

Gut microbiota may be the key factor explaining why certain individuals do not respond well to the pneumococcal vaccine-a bacterium that can cause various diseases, such as pneumonia.

Gut microbiota may be the key factor explaining why certain individuals do not respond well to the pneumococcal vaccine-a bacterium that can cause ...

Kenox Pharma partners with Lactiga for development of novel mucosal-targeted Secretory IgA therapies for immunodeficient patients: Princeton, New Jersey Wednesday, March 12, 2025, ...

Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with late AMRAMR is a ...

A new vaccine pill trial is currently underway to treat the highly contagious norovirus infection, which has led to a record ...

In an early clinical trial, an experimental norovirus vaccine given as a pill produced defensive responses exactly where it ...

Antibodies are secreted immunoglobulin molecules produced mainly by plasma cells. The antigen-binding site of the antibody has a unique structure that allows it to bind antigen in a highly ...

Vaxart (VXRT) announced that complete data from the Phase 1b trial of its first-generation oral pill norovirus vaccine candidate in elderly ...